Vesnarinone (INN) is a cardiotonic agent.

[1] A mixed phosphodiesterase 3 inhibitor and ion-channel modifier that has modest, dose-dependent, positive inotropic activity, but minimal negative chronotropic activity.

Vesnarinone improves ventricular performance most in patients with the worst degree of heart failure.

This drug article relating to the cardiovascular system is a stub.

You can help Wikipedia by expanding it.